Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration



Status:Completed
Conditions:Ocular
Therapuetic Areas:Ophthalmology
Healthy:No
Age Range:50 - Any
Updated:4/21/2016
Start Date:October 2014
End Date:June 2015

Use our guide to learn which trials are right for you!

A Combined Phase IIa / IIb Study of the Efficacy, Safety, and Tolerability of Repeated Topical Doses of Regorafenib Eye Drops, in Treatment-naïve Subjects With Neovascular Age Related Macular Degeneration

Part A (Phase IIa):

Primary objectives:

The study part A is designed to investigate whether the use of regorafenib eye drops can
help patients with neovascular (wet) Age-Related Macular Degeneration (wAMD) to see better
after 4 weeks and 12 weeks after inclusion into this study.

Secondary objectives:

The study will also evaluate the safety and tolerability of the regorafenib eye drops.

Part B (Phase IIb):

Primary objectives:

The study part B is designed to investigate:

- how often the regorafenib eye drops need to be given per day

- whether the use of regorafenib eye drops can help patients with neovascular (wet)
Age-Related Macular Degeneration (wAMD) to see better after 4 weeks and 12 weeks after
inclusion into this study.

Secondary objectives:

The study will also evaluate how the different dosings of regorafenib eye drops affect
patients vision, the safety and the tolerability.


Inclusion Criteria:

- Able to read (or, if unable to read due to visual impairment, be read to verbatim by
the person administering the informed consent or a family member) and able to
understand the informed consent form (ICF)

- Men and women ≥ 50 years of age

- Active primary subfoveal CNV (Choroidal neovascularization) lesions secondary to AMD
(Age-related macular degeneration), including juxtafoveal lesions that affect the
fovea as evidenced by FA (Fluorescein angiography) in the study eye and reviewed by
the central reading center

- The area of CNV must occupy at least 50% of total lesion in the study eye, as
determined by FA review at the central reading center

- Evidence of intraretinal and/or subretinal fluid on OCT (Optical coherence
tomography)

- Early Treatment Diabetic Retinopathy Study BCVA of 73 to 25 letters (20/40 to 20/320
Snellen equivalent) in the study eye

- Willing, committed, and able to return for all clinic visits and complete all study
related procedures

- Women of childbearing potential and men must agree to use adequate contraception when
sexually active. This applies since signing of the ICF until one month after the EOS
visit. The definition of adequate contraception will be based on the judgment of the
investigator.

Exclusion Criteria:

- Concurrent disease in the study eye, other than AMD (e.g., corneal diseases and
dystrophies, conjunctival diseases, eye lid abnormalities, or any other diseases of
the cornea and macula, or optic nerve abnormality) that could compromise visual
acuity, likely require medical or surgical intervention during the study period,
would limit the potential to gain or lose vision during study treatment, or could
otherwise confound interpretation of the results

- Total lesion size (including neovascularization, scar, blood) > 12 disc areas (30.5
mm2) as assessed by FA

- Only one functional eye, even if that eye is otherwise eligible for the study

- Prior ocular or systemic treatment or surgery for neovascular AMD in the study eye
except dietary supplements or vitamins

- Prior treatment with any systemic anti-VEGF (Vascular endothelial growth factor)
agent

- Use of systemic or ocular treatment with an investigational drug within 12 weeks
prior to start of study treatment

- Any other condition that would require frequent chronic co-administration of other
topical eye medications that would interfere with study drug administration (e.g.
contact lens)

- Symptoms or conditions consistent with contraindications listed in the current local
label for ranibizumab

- Participation in an investigational study within 30 days prior to start of study
treatment that involved treatment with any drug (excluding vitamins and minerals) or
device

- Lactating women and women of child-bearing potential with either a positive pregnancy
test result or no pregnancy test at screening are excluded. Postmenopausal women must
be amenorrheic for at least 12 months in order not to be considered of child bearing
potential.
We found this trial at
39
sites
2092
mi
from 43215
Campbell, CA
Click here to add this to my saved trials
1960
mi
from 43215
Arcadia, CA
Click here to add this to my saved trials
302
mi
from 43215
Asheville, NC
Click here to add this to my saved trials
1069
mi
from 43215
Austin, TX
Click here to add this to my saved trials
Beverly Hills, California 90211
1979
mi
from 43215
Beverly Hills, CA
Click here to add this to my saved trials
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
943
mi
from 43215
Boynton Beach, FL
Click here to add this to my saved trials
278
mi
from 43215
Charlottesville, VA
Click here to add this to my saved trials
1964
mi
from 43215
Costa Mesa, CA
Click here to add this to my saved trials
430
mi
from 43215
Decatur, GA
Click here to add this to my saved trials
841
mi
from 43215
Eunice, LA
Click here to add this to my saved trials
398
mi
from 43215
Florissant, MO
Click here to add this to my saved trials
922
mi
from 43215
Fort Myers, FL
Click here to add this to my saved trials
1174
mi
from 43215
Golden, CO
Click here to add this to my saved trials
248
mi
from 43215
Grand Rapids, MI
Click here to add this to my saved trials
Greenville, South Carolina 29605
358
mi
from 43215
Greenville, SC
Click here to add this to my saved trials
Greenville, South Carolina 29605
358
mi
from 43215
Greenville, SC
Click here to add this to my saved trials
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
1956
mi
from 43215
Laguna Hills, CA
Click here to add this to my saved trials
623
mi
from 43215
Leawood, KS
Click here to add this to my saved trials
188
mi
from 43215
Louisville, KY
Click here to add this to my saved trials
1291
mi
from 43215
McAllen, TX
Click here to add this to my saved trials
993
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Mountain View, California 94040
2097
mi
from 43215
Mountain View, CA
Click here to add this to my saved trials
189
mi
from 43215
New Albany, IN
Click here to add this to my saved trials
970
mi
from 43215
Plantation, FL
Click here to add this to my saved trials
1071
mi
from 43215
Rapid City, SD
Click here to add this to my saved trials
1144
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
1960
mi
from 43215
Santa Ana, CA
Click here to add this to my saved trials
874
mi
from 43215
Sarasota, FL
Click here to add this to my saved trials
Strathfield, New South Wales 2135
9463
mi
from 43215
Strathfield,
Click here to add this to my saved trials
896
mi
from 43215
Stuart, FL
Click here to add this to my saved trials
477
mi
from 43215
Teaneck, NJ
Click here to add this to my saved trials
1009
mi
from 43215
Temple, TX
Click here to add this to my saved trials
974
mi
from 43215
The Woodlands, TX
Click here to add this to my saved trials
1639
mi
from 43215
Tucson, AZ
Click here to add this to my saved trials
168
mi
from 43215
West Mifflin, PA
Click here to add this to my saved trials
784
mi
from 43215
Wichita, KS
Click here to add this to my saved trials
830
mi
from 43215
Winter Haven, FL
Click here to add this to my saved trials